Claudin18.2-targeted Activated Dendritic Cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Claudin18.2-targeted Activated Dendritic Cells, covering 2026-02-18 to 2026-02-18. Get the full timeline:
Most recent: Clinical Trial Update: Exploratory Clinical Study of Claudin18.2-Targeted Activated DC and CAR-T Therapy in Advanced Pancreatic Cancer. [EARLY_Phase 1]